Verano Holdings (VRNO) Profit After Tax (2021 - 2026)
Verano Holdings' (VRNO) quarterly Profit After Tax came in at -$17.8 million in Q1 2026, down 54.78% year-on-year from -$39.4 million in Q1 2025, and up 90.28% on a QoQ basis from -$183.4 million in Q4 2025.
Verano Holdings (VRNO) Profit After Tax (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Profit After Tax data on file, last reported at -$17.8 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 54.78% year-over-year to -$17.8 million in Q1 2026; TTM through Mar 2026 was -$264.2 million, a 24.2% increase from a year earlier, with the FY2025 full-year figure at -$257.9 million, up 24.56% from the prior year.
- Profit After Tax for Q1 2026 stood at -$17.8 million, up from -$183.4 million in the prior quarter.
- Over the last five years, Profit After Tax for VRNO reached as high as -$214000.0 in Q1 2022 and fell as low as -$272.7 million in Q4 2024.
- Historically, Profit After Tax has averaged -$59.1 million across 5 years, with a median of -$19.2 million in 2025.
- Across the five-year window, Profit After Tax surged 66.72% in 2022 and sank 4216.36% in 2023, its largest moves.
- Year by year, Profit After Tax stood at -$216.1 million in 2022, then surged by 64.27% to -$77.2 million in 2023, then slumped by 253.21% to -$272.7 million in 2024, then jumped by 32.74% to -$183.4 million in 2025, then soared by 90.28% to -$17.8 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$17.8 million in Q1 2026, -$183.4 million in Q4 2025, and -$43.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | -17.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.82 Mn |
| Dec 31, 2025 | -183.41 Mn |
| Sep 30, 2025 | -43.83 Mn |
| Jun 30, 2025 | -19.15 Mn |
| Mar 31, 2025 | -11.52 Mn |
| Dec 31, 2024 | -272.71 Mn |
| Sep 30, 2024 | -42.57 Mn |
| Jun 30, 2024 | -21.76 Mn |
| Mar 31, 2024 | -4.82 Mn |
| Dec 31, 2023 | -77.21 Mn |
| Sep 30, 2023 | -17.84 Mn |
| Jun 30, 2023 | -13.06 Mn |
| Mar 31, 2023 | -9.24 Mn |
| Dec 31, 2022 | -216.11 Mn |
| Sep 30, 2022 | -42.99 Mn |
| Jun 30, 2022 | -9.85 Mn |
| Mar 31, 2022 | -214,000.00 |
| Dec 31, 2021 | -6.83 Mn |
| Sep 30, 2021 | -12.51 Mn |
| Jun 30, 2021 | -29.59 Mn |